Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Improved persistence and expanded TPEX formation in Regnase-1 KO CAR T cells is TCF-1-dependent
PubMed Full text in PMC Similar studies Analyze with GEO2R
Regnase-1 suppresses TCF-1+ precursor exhausted T cell formation to limit CAR T cell responses against ALL [WGBS]
PubMed Full text in PMC Similar studies SRA Run Selector
Regnase-1 suppresses TCF-1+ precursor exhausted T cell formation to limit CAR T cell responses against ALL
Regnase-1 KO CAR T cell reprogramed to memory-like cells
Regnase-1 suppresses TCF-1+ precursor exhausted T cell formation to limit CAR T cell responses against ALL [Microarray Expression]
CD19-CAR T cells undergo exhaustion epigenetic programming in patients with acute lymphoblastic leukemia
PubMed Full text in PMC Similar studies
Next Generation Sequencing of Chimeric antigen receptor T (CAR-T) cells polarized under Th9 condition
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
FOXO1 is a master regulator of CAR T memory programming [scRNA_FOXO1_NGFR]
FOXO1 is a master regulator of CAR T memory programming
FOXO1 is a master regulator of CAR T memory programming [ATAC_FOXO1_OE]
FOXO1 is a master regulator of CAR T memory programming [RNA_FOXO1_DBO]
FOXO1 is a master regulator of CAR T memory programming [RNA_Dual_OE-KO]
FOXO1 is a master regulator of CAR T memory programming [RNA_FOXO1_OE]
FOXO1 is a master regulator of CAR T memory programming [ATAC_FOXO1]
FOXO1 is a master regulator of CAR T memory programming [RNA_FOXO1_KO]
FOXO1 is a master regulator of CAR T memory programming [RNA_FOXO1_OE_CD4]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [microarray]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on